设计,合成和生物评估新型2-Heteroaryl-oxazolidine-4-one衍生物作为新型HBV囊组装调节器
Xuefen Tao1, Yuan Wang2, Yunwen Wang2
1Taizhou Vocational & Technical College.
Biological & pharmaceutical bulletin
|December 8, 2024
概括
研究人员合成了新型的oxazolidinone衍生物来抑制乙型肝炎病毒 (HBV) DNA. 化合物7g显示出强大的抗HBV活性,作为一种具有低毒性的潜在HBV囊组装调节器.
科学领域:
- 药用化学 医学化学
- 病毒学 病毒学
- 有机合成 有机合成
背景情况:
- 乙型肝炎病毒 (HBV) 感染仍然是一个重大的全球健康挑战.
- 开发新的抗病毒药物对于管理慢性HBV至关重要.
- 奥克萨索利丁衍生物已经显示出作为抗病毒化合物的前景.
研究的目的:
- 为了设计和合成新型的2-heteroaryl-oxazolidinone衍生物.
- 评估它们对抗HBVDNA增殖的抑制活性.
- 为了识别潜在的HBV囊组装调节器.
主要方法:
- 在化合物1中用生物异构的方法替换pyrazole部分,使用各种异环.
- 使用核磁共振 (NMR) 和质谱法 (MS) 阐明结构.
- 在体外抗病毒测试以确定抗HBV活性和细胞毒性.
主要成果:
- 一系列新型2-heteroaryl-oxazolidinone衍生物的合成.
- 大多数化合物表现出中度到良好的HBVDNA增殖抑制与低细胞毒性.
- 化合物7g显示出最强的抗HBV活性 (EC50 = 0.059μM) 和一个有利的选择性指数.
结论:
- 该研究确定了新型佐利丁衍生物的结构-活性关系 (SAR).
- 化合物7g被确定为HBV囊组装调节器的有希望的候选者.
- 需要对7g化合物进行进一步的研究,以确定其对抗HBV的治疗潜力.
更多相关视频
05:55Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
6.7K
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.1K
相关概念视频
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
